Figitumumab (CP-751871) is a highly potent, fully human monoclonal antibody of the IgG2 isotype that specifically targets the insulin-like growth factor 1 receptor (IGF1R). it functions by competitively inhibiting the binding of IGF1 to its receptor with a IC50 of 1.8 nM. Figitumumab can be used in studies about advanced squamous cell carcinoma of the lung.
Purity:
95%
CAS Number:
[943453-46-1]
Target:
IGF-1R
* VAT and and shipping costs not included. Errors and price changes excepted
